The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...

Abogen Biosciences makes it on this list by virtue of an impressive $700 million series C round that it bagged in August 2021 – still one of the biggest ever private biotech funding rounds. This was ...

Given the rise of artificial intelligence (AI) in the biotechnology industry in the last few years, it is no surprise that AI specialists represent a career in high demand right now – a trend that ...

Messenger RNAs (mRNAs) work with DNA molecules to make our bodies function properly. They carry the genetic information stored in DNA, and translate them into proteins, which help control cell ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...